Martingale Asset Management L P Rvl Pharmaceuticals PLC Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.8 - $3.78 $52,640 - $71,064	-18,800 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.26 - $4.84 $19,915 - $29,567	-6,109 Reduced 24.53%	18,800 $61,000
Q4 2020 Feb 10, 2021	SELL	$4.12 - $6.29 $162,933 - $248,750	-39,547 Reduced 61.36%	24,909 $102,000
Q3 2020 Nov 12, 2020	BUY	$4.82 - $8.77 $17,896 - $32,563	3,713 Added 6.11%	64,456 $348,000
Q2 2020 Aug 10, 2020	BUY	$2.83 - $6.99 $16,988 - $41,960	6,003 Added 10.97%	60,743 $408,000
Q1 2020 May 11, 2020	BUY	$3.18 - $7.0 $21,306 - $46,900	6,700 Added 13.95%	54,740 $174,000
Q4 2019 Feb 10, 2020	BUY	$3.46 - $7.7 $166,218 - $369,908	48,040 New	48,040 $335,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.